A new era, new vision for WuXi and NextCODE Health
Hannes Smarason Genome Sequencing |Personalized Medicine | Transforming Health Care
Our Opportunity: Enhance Value of Genomics in Medicine
In the fast-‐paced genomics community, we con?nually look for new opportuni?es and strategies to enhance the value of genomics and use the increasingly robust body of genomic data for the advancement of clinical medicine.
We’re excited to announce a new, ambi?ous vision to do just that, with WuXi’s acquisi?on of NextCODE Health.
NextCODE and WuXi
• NextCODE will be merged with WuXi’s exis?ng Genome Center in wholly-‐owned subsidiary called WuXi NextCODE Genomics, with unique, comprehensive and global capabili?es for using genomic data to deliver beOer medicine and improve healthcare.
Increased Value Through CollaboraIon • WuXi, a Shanghai-‐based genomic laboratory service partner for companies in the pharma and biotech community, has already been collabora?ng with NextCODE to provide analysis services to customers of the WuXi Genome Center.
• Now, with the in-‐house capability to analyze, store and manage the vast amount of genomic data, NextCODE’s industry leading genome sequence analysis plaPorm will expand WuXi’s core NGS benefits and services.
Enhancing CapabiliIes and ContribuIons
• Pairing WuXi’s technology and exis?ng reach with NextCODE’s leading analy?cs and database promises to advance the pace of genomics research today.
• More importantly, however, this new era for our company brings exci?ng opportuni?es to maximize the most advanced tools available today and contribute to major advances in genomic medicine.
Top Related